This leads to inhibition of VEGF downstream signaling via VEGF receptor 2 (VEGFR2) that requires activation of Src [26], whereas Ang-2 has been shown to be synergistic with VEGF in tumor angiogenesis and permeability including in brain tumors that are characterized by significant BBB damage [64]. Here, KDR is linked to neoplasm.